Resources

A new study released in the scientific journal Nutrition & Metabolism found that type 2 diabetes can be managed and controlled simply by minor changes in the diet alone without the need for weight loss or the use of insulin medications.

Empire Study: Effects of Rosiglitazone + Submaximal Doses of Metformin Verses Increasing Does of Metromin in Type 2 Diabetes Addition of Rosiglitazone to submaximal doses of MET may be a suitable alternative to the maximal effective dose of MET monotherapy.

Mitiglinide plus insulin glargine combination therapy is useful for lowering both fasting and postprandial hyperglycemia in a subpopulation of type 2 diabetes.

Obese and overweight individuals suffering Type 2 diabetes showed significant health improvements after only three weeks of diet and moderate exercise even though the participants remained overweight.

Physicians and educators should be also targeting postprandial regulation, which has been shown to improve glucose control and to reduce the progression of atherosclerosis and CV events.

Contraception with depo-medroxyprogesterone acetate (DMPA) is associated with an increase in the risk of diabetes in some Latino women with prior gestational diabetes.

Up to 75 percent of the increase in body weight that can occur in patients with type 2 diabetes who are treated with pioglitazone is from water retention but the drug also tends to reduce abdominal fat and blood pressure.

A once-daily pill of low-dose aspirin helps lower the potential for clot-forming blood cells – in both men and women – to stick together in narrow blood vessels.

Diabetics who were prescribed newer medications to control their illness were more likely to take these drugs as instructed than were other patients who were prescribed drugs that have been on the market for several decades.

PAD is common in patients with type 2 diabetes and predicts cardiac death, supporting the role of regular screening for PAD in these patients.